Literature DB >> 25728792

Theophylline Pharmacokinetics in Foetal Sheep: Maternal Metabolic Capacity is the Principal Driver.

Barent DuBois1,2, Samantha Louey3, George D Giraud3,4, Ganesh Cherala1,2,3, Sonnet S Jonker3.   

Abstract

Understanding theophylline pharmacokinetics (PK) in the foetus is essential to prevent in utero toxicity and optimize prophylactic therapies. Previous studies in pregnancy have been obfuscated by maternal dosing and inadequate sampling in the foetus; both render modelling of foetal PK difficult. Six ewes carrying singleton foetuses received theophylline (60 mg) into the foetal jugular vein. Blood samples were drawn from the foetus and ewe over 36 hr. Serum concentrations were measured. Maternal and foetal pharmacokinetic parameters were estimated. Foetal non-compartmental pharmacokinetic parameters were as follows: half-life 7.37 ± 1.22 hr; volume of distribution 44.62 ± 11.45 L; area under the curve 14.82 ± 2.71 hr/(μg/mL); and clearance 4.15 ± 0.70 L/hr. Rapid theophylline distribution across the placenta was observed. Maternal non-compartmental pharmacokinetic parameters were as follows: half-life 6.54 ± 2.44 hr; volume of distribution 32.48 ± 9.99 L; area under the curve 16.28 ± 4.53 hr/(μg/mL); and clearance 3.69 ± 1.47 L/hr. Foetal and ewe serum concentration-time profiles were fit together into a 3-compartment population pharmacokinetic model, and parameters were as follows: central volume 1.38 ± 0.11 L; 2nd peripheral compartment volume 3.11 ± 0.29 L; 3rd peripheral compartment volume 60.14 ± 6.02 L; elimination clearance 9.89 ± 0.90 L/hr; distribution clearance between central and 2nd compartment 30.87 ± 2.31 L/hr; and distribution clearance between 2nd and 3rd compartments 13.89 ± 1.11 L/hr. Cytochrome P4501A expression was robust in maternal liver; negligible activities were observed in placenta, foetal liver and foetal kidney. In vitro protein binding of theophylline was 30% lower in foetal serum compared to maternal serum (29.7 ± 4.4 versus 42.0 ± 3.6%-bound). Free concentrations were lower in the foetus than in the ewe, suggesting active transport across placenta. In summary, foetal clearance of theophylline is attributable to rapid distribution into the maternal circulation across the placenta followed by greater maternal protein binding and metabolic activity.
© 2015 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25728792      PMCID: PMC4750914          DOI: 10.1111/bcpt.12395

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  33 in total

1.  Fetal breathing, sleep state, and cardiovascular responses to adenosine in sheep.

Authors:  B J Koos; K Matsuda
Journal:  J Appl Physiol (1985)       Date:  1990-02

Review 2.  Volumes of distribution.

Authors:  P L Toutain; A Bousquet-Mélou
Journal:  J Vet Pharmacol Ther       Date:  2004-12       Impact factor: 1.786

3.  Pharmacokinetics of glycopyrrolate following intravenous administration in the horse.

Authors:  M J Rumpler; R A Sams; P Colahan
Journal:  J Vet Pharmacol Ther       Date:  2011-03-02       Impact factor: 1.786

4.  An isocratic high-performance liquid chromatographic system for simultaneous determination of theophylline and its major metabolites in human urine.

Authors:  H Tajerzadeh; S Dadashzadeh
Journal:  J Pharm Biomed Anal       Date:  1995-11       Impact factor: 3.935

5.  Placental transfer of theophylline in an in vitro closed perfusion system of human placenta isolated lobule.

Authors:  D Omarini; M M Barzago; A Bortolotti; G Lucchini; F Stellari; S Efrati; M Bonati
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Oct-Dec       Impact factor: 2.441

6.  Pharmacokinetics and metabolism of natural methylxanthines in animal and man.

Authors:  Maurice J Arnaud
Journal:  Handb Exp Pharmacol       Date:  2011

7.  Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat.

Authors:  M V St-Pierre; T Stallmach; A Freimoser Grundschober; J-F Dufour; M A Serrano; J J G Marin; Y Sugiyama; P J Meier
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-09-02       Impact factor: 3.619

8.  Adenosine mediates metabolic and cardiovascular responses to hypoxia in fetal sheep.

Authors:  B J Koos; A Chau; D Ogunyemi
Journal:  J Physiol       Date:  1995-11-01       Impact factor: 5.182

9.  Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine.

Authors:  H Saitoh; B J Aungst
Journal:  Pharm Res       Date:  1995-09       Impact factor: 4.200

10.  In Vitro Drug Absorption Models. II. Salicylate, Cefoxitin, α-Methyldopa and Theophylline Uptake in Cells and Rings: Correlation with In Vivo Bioavailability.

Authors:  P A Porter; I Osiecka; R T Borchardt; J A Fix; L Frost; C Gardner
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

View more
  1 in total

Review 1.  Thyroid hormone signaling and consequences for cardiac development.

Authors:  Natasha N Chattergoon
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.